$ALXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALEXION PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALEXION PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 17 18 19 20 21 22 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Option Exercise | M | 16.10 | 625 | 10,063 | 0 | ||
Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Option Exercise | M | 16.10 | 625 | 10,063 | 0 | ||
Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Option Exercise | M | 18.16 | 5,506 | 99,989 | 0 | ||
Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Option Exercise | M | 18.16 | 4,494 | 81,611 | 0 | ||
Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Sell | S | 23.47 | 5,000 | 117,350 | 0 | 5 K to 0 (-100.00 %) | |
Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Sell | S | 23.40 | 3,000 | 70,200 | 0 | 3 K to 0 (-100.00 %) | |
Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Sell | S | 23.27 | 3,250 | 75,628 | 0 | 3.3 K to 0 (-100.00 %) | |
Jun 15 2005 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Senior Vice Preside ... | Sell | S | 21.57 | 3,000 | 64,718 | 40,196 | 43.2 K to 40.2 K (-6.95 %) |
Jun 08 2005 | ALXN | ALEXION PHARMACEUT ... | ROLLINS SCOTT A | Sr. VP Drug Dev. & ... | Sell | S | 22.25 | 1,900 | 42,275 | 3,100 | 5 K to 3.1 K (-38.00 %) |
Jun 08 2005 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Option Exercise | M | 2.38 | 6,800 | 16,150 | 0 | |
Jun 08 2005 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Sell | S | 21.88 | 1,800 | 39,384 | 55,000 | 56.8 K to 55 K (-3.17 %) |
Jun 08 2005 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Buy | M | 2.38 | 6,800 | 16,150 | 56,800 | 50 K to 56.8 K (+13.60 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.00 | 15,095 | 150,950 | 0 | |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | M | 10.00 | 29,905 | 299,050 | 0 | |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.41 | 9,494 | 193,773 | 4,000 | 13.5 K to 4 K (-70.36 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.43 | 2,849 | 58,205 | 13,494 | 16.3 K to 13.5 K (-17.43 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.32 | 3,000 | 60,951 | 16,343 | 19.3 K to 16.3 K (-15.51 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.50 | 2,700 | 55,350 | 19,343 | 22 K to 19.3 K (-12.25 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.52 | 600 | 12,312 | 22,043 | 22.6 K to 22 K (-2.65 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.53 | 100 | 2,053 | 22,643 | 22.7 K to 22.6 K (-0.44 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.54 | 600 | 12,324 | 22,743 | 23.3 K to 22.7 K (-2.57 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.56 | 100 | 2,056 | 23,343 | 23.4 K to 23.3 K (-0.43 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.54 | 1,086 | 22,308 | 23,443 | 24.5 K to 23.4 K (-4.43 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.60 | 9,500 | 195,700 | 24,529 | 34 K to 24.5 K (-27.92 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.65 | 417 | 8,611 | 34,029 | 34.4 K to 34 K (-1.21 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.80 | 1,302 | 27,082 | 34,446 | 35.7 K to 34.4 K (-3.64 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.98 | 500 | 10,491 | 35,748 | 36.2 K to 35.7 K (-1.38 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.02 | 1,827 | 38,404 | 36,248 | 38.1 K to 36.2 K (-4.80 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.03 | 1,073 | 22,565 | 38,075 | 39.1 K to 38.1 K (-2.74 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.10 | 5,300 | 111,830 | 39,148 | 44.4 K to 39.1 K (-11.92 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.11 | 100 | 2,111 | 44,448 | 44.5 K to 44.4 K (-0.22 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.14 | 300 | 6,342 | 44,548 | 44.8 K to 44.5 K (-0.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.15 | 700 | 14,805 | 44,848 | 45.5 K to 44.8 K (-1.54 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.16 | 700 | 14,812 | 45,548 | 46.2 K to 45.5 K (-1.51 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 20.95 | 1,267 | 26,545 | 46,248 | 47.5 K to 46.2 K (-2.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.00 | 7,900 | 165,900 | 47,515 | 55.4 K to 47.5 K (-14.26 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.01 | 3,433 | 72,127 | 55,415 | 58.8 K to 55.4 K (-5.83 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.01 | 587 | 12,333 | 58,848 | 59.4 K to 58.8 K (-0.99 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.02 | 400 | 8,408 | 59,435 | 59.8 K to 59.4 K (-0.67 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.04 | 900 | 18,936 | 59,835 | 60.7 K to 59.8 K (-1.48 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.04 | 500 | 10,521 | 60,735 | 61.2 K to 60.7 K (-0.82 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 21.05 | 108 | 2,273 | 61,235 | 61.3 K to 61.2 K (-0.18 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.00 | 15,095 | 150,950 | 61,343 | 46.2 K to 61.3 K (+32.64 %) |
May 03 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Buy | M | 10.00 | 29,905 | 299,050 | 46,248 | 16.3 K to 46.2 K (+182.98 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Option Exercise | A | 20.38 | 8,000 | 163,040 | 8,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Grant | A | 0.00 | 4,000 | 0 | 15,876 | 11.9 K to 15.9 K (+33.68 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | VP & General Counse ... | Option Exercise | A | 20.38 | 6,000 | 122,280 | 6,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | DUBIN THOMAS I H | VP & General Counse ... | Grant | A | 0.00 | 3,000 | 0 | 5,000 | 2 K to 5 K (+150.00 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Senior Vice Preside ... | Option Exercise | A | 20.38 | 6,000 | 122,280 | 6,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Senior Vice Preside ... | Grant | A | 0.00 | 3,000 | 0 | 33,196 | 30.2 K to 33.2 K (+9.94 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | MOTOLA NANCY | Sr. VP Regulatory & ... | Option Exercise | A | 20.38 | 6,000 | 122,280 | 6,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | MOTOLA NANCY | Sr. VP Regulatory & ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | Sr. VP Clinical Dev ... | Option Exercise | A | 20.38 | 6,000 | 122,280 | 6,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | MOJCIK CHRISTOPHER F | Sr. VP Clinical Dev ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | A | 20.38 | 8,000 | 163,040 | 8,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Grant | A | 0.00 | 4,000 | 0 | 69,500 | 65.5 K to 69.5 K (+6.11 %) |
Feb 02 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 25.01 | 4,500 | 112,545 | 282,145 | 286.6 K to 282.1 K (-1.57 %) |
Feb 02 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 25.06 | 500 | 12,530 | 286,645 | 287.1 K to 286.6 K (-0.17 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | A | 20.38 | 22,500 | 458,550 | 22,500 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Grant | A | 0.00 | 11,250 | 0 | 293,395 | 282.1 K to 293.4 K (+3.99 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP Finance & Admini ... | Option Exercise | A | 20.38 | 2,500 | 50,950 | 2,500 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | LUKE BARRY P | VP Finance & Admini ... | Grant | A | 0.00 | 1,250 | 0 | 24,555 | 23.3 K to 24.6 K (+5.36 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | ROLLINS SCOTT A | Sr. VP Drug Dev. & ... | Option Exercise | A | 20.38 | 6,000 | 122,280 | 6,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | ROLLINS SCOTT A | Sr. VP Drug Dev. & ... | Grant | A | 0.00 | 3,000 | 0 | 5,000 | 2 K to 5 K (+150.00 %) |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Vice President & CF ... | Option Exercise | A | 20.38 | 6,000 | 122,280 | 6,000 | |
Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Vice President & CF ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Mar 10 2005 | ALXN | ALEXION PHARMACEUT ... | JACKSON JERRY T | Option Exercise | A | 20.38 | 5,000 | 101,900 | 5,000 | ||
Mar 10 2005 | ALXN | ALEXION PHARMACEUT ... | JACKSON JERRY T | Option Exercise | M | 10.74 | 1,334 | 14,327 | 0 | ||
Mar 10 2005 | ALXN | ALEXION PHARMACEUT ... | JACKSON JERRY T | Option Exercise | M | 14.13 | 7,500 | 105,938 | 0 | ||
Mar 10 2005 | ALXN | ALEXION PHARMACEUT ... | JACKSON JERRY T | Grant | A | 0.00 | 1,300 | 0 | 1,300 | 0 to 1.3 K | |
Mar 10 2005 | ALXN | ALEXION PHARMACEUT ... | JACKSON JERRY T | Sell | S | 20.19 | 8,834 | 178,358 | 0 | 8.8 K to 0 (-100.00 %) | |
Mar 10 2005 | ALXN | ALEXION PHARMACEUT ... | JACKSON JERRY T | Grant | A | 10.74 | 1,334 | 14,327 | 8,834 | 7.5 K to 8.8 K (+17.79 %) | |
Mar 10 2005 | ALXN | ALEXION PHARMACEUT ... | JACKSON JERRY T | Grant | A | 14.13 | 7,500 | 105,938 | 7,500 | 0 to 7.5 K | |
Mar 09 2005 | ALXN | ALEXION PHARMACEUT ... | Waeger Ruedi E | Director | Option Exercise | A | 20.54 | 12,000 | 246,480 | 12,000 | |
Jan 31 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | M | 2.38 | 11,500 | 27,313 | 0 | |
Jan 31 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 24.70 | 4,500 | 111,150 | 65,500 | 70 K to 65.5 K (-6.43 %) |
Jan 31 2005 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Buy | M | 2.38 | 11,500 | 27,313 | 70,000 | 58.5 K to 70 K (+19.66 %) |
Jan 19 2005 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 24.61 | 2,387 | 58,744 | 287,145 | 289.5 K to 287.1 K (-0.82 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 19,332 | 45,914 | 0 | |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 25.03 | 9,279 | 232,253 | 289,532 | 298.8 K to 289.5 K (-3.11 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 19,332 | 45,914 | 298,811 | 279.5 K to 298.8 K (+6.92 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | D | 17.05 | 2,500 | 42,625 | 5,000 | |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | D | 15.58 | 2,500 | 38,950 | 2,500 | |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 17.05 | 2,500 | 42,625 | 42,657 | 40.2 K to 42.7 K (+6.23 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Buy | P | 15.58 | 2,500 | 38,950 | 40,157 | 37.7 K to 40.2 K (+6.64 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | M | 2.38 | 7,500 | 17,813 | 11,500 | |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | M | 2.38 | 4,000 | 9,500 | 0 | |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 24.75 | 200 | 4,950 | 58,500 | 58.7 K to 58.5 K (-0.34 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 24.71 | 200 | 4,942 | 58,700 | 58.9 K to 58.7 K (-0.34 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 24.70 | 4,100 | 101,270 | 58,900 | 63 K to 58.9 K (-6.51 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Buy | M | 2.38 | 7,500 | 17,813 | 63,000 | 55.5 K to 63 K (+13.51 %) |
Dec 30 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Buy | M | 2.38 | 4,000 | 9,500 | 55,500 | 51.5 K to 55.5 K (+7.77 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.15 | 3,150 | 79,223 | 11,876 | 15 K to 11.9 K (-20.96 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.20 | 100 | 2,520 | 15,026 | 15.1 K to 15 K (-0.66 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.22 | 1,150 | 29,003 | 15,126 | 16.3 K to 15.1 K (-7.07 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.23 | 100 | 2,523 | 16,276 | 16.4 K to 16.3 K (-0.61 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.24 | 400 | 10,096 | 16,376 | 16.8 K to 16.4 K (-2.38 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.24 | 540 | 13,630 | 16,776 | 17.3 K to 16.8 K (-3.12 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.00 | 9,000 | 225,000 | 17,316 | 26.3 K to 17.3 K (-34.20 %) |
Dec 21 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | J | 0.00 | 467 | 0 | 12,343 | 11.9 K to 12.3 K (+3.93 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP & Head of Resea ... | Sell | S | 25.00 | 1,810 | 45,250 | 26,316 | 28.1 K to 26.3 K (-6.44 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 10,417 | 24,740 | 19,332 | |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 25.01 | 5,000 | 125,050 | 279,479 | 284.5 K to 279.5 K (-1.76 %) |
Dec 20 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 10,417 | 24,740 | 284,479 | 274.1 K to 284.5 K (+3.80 %) |
Dec 16 2004 | ALXN | ALEXION PHARMACEUT ... | BOWDISH KATHERINE S | Senior Vice Preside ... | Sell | S | 24.10 | 5,000 | 120,476 | 30,196 | 35.2 K to 30.2 K (-14.21 %) |
Dec 14 2004 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | A | 22.21 | 7,500 | 166,575 | 7,500 | |
Dec 14 2004 | ALXN | ALEXION PHARMACEUT ... | LINK MAX | Director | Option Exercise | A | 22.21 | 7,500 | 166,575 | 7,500 | |
Dec 14 2004 | ALXN | ALEXION PHARMACEUT ... | NORBY R DOUGLAS | Director | Option Exercise | A | 22.21 | 7,500 | 166,575 | 7,500 | |
Dec 14 2004 | ALXN | ALEXION PHARMACEUT ... | MATHIS LARRY | Director | Option Exercise | A | 22.21 | 7,500 | 166,575 | 7,500 | |
Dec 14 2004 | ALXN | ALEXION PHARMACEUT ... | MADRI JOSEPH A | Director | Option Exercise | A | 22.21 | 7,500 | 166,575 | 7,500 | |
Dec 01 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Option Exercise | M | 2.38 | 11,500 | 27,313 | 4,000 | |
Dec 01 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Sell | S | 20.02 | 4,500 | 90,090 | 51,500 | 56 K to 51.5 K (-8.04 %) |
Dec 01 2004 | ALXN | ALEXION PHARMACEUT ... | KEISER DAVID W | President & Chief O ... | Buy | M | 2.38 | 11,500 | 27,313 | 56,000 | 44.5 K to 56 K (+25.84 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 37,959 | 90,153 | 29,749 | |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Option Exercise | M | 2.38 | 5,791 | 13,754 | 0 | |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.20 | 10,000 | 202,000 | 274,062 | 284.1 K to 274.1 K (-3.52 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.25 | 4,500 | 91,125 | 284,062 | 288.6 K to 284.1 K (-1.56 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.26 | 200 | 4,052 | 288,562 | 288.8 K to 288.6 K (-0.07 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.27 | 100 | 2,027 | 288,762 | 288.9 K to 288.8 K (-0.03 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.28 | 100 | 2,028 | 288,862 | 289 K to 288.9 K (-0.03 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.29 | 100 | 2,029 | 288,962 | 289.1 K to 289 K (-0.03 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.30 | 3,600 | 73,080 | 289,062 | 292.7 K to 289.1 K (-1.23 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.31 | 300 | 6,093 | 292,662 | 293 K to 292.7 K (-0.10 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.32 | 1,000 | 20,320 | 292,962 | 294 K to 293 K (-0.34 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.35 | 100 | 2,035 | 293,962 | 294.1 K to 294 K (-0.03 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.45 | 2,165 | 44,274 | 294,062 | 296.2 K to 294.1 K (-0.73 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.46 | 200 | 4,092 | 296,227 | 296.4 K to 296.2 K (-0.07 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.47 | 635 | 12,998 | 296,427 | 297.1 K to 296.4 K (-0.21 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.48 | 500 | 10,240 | 297,062 | 297.6 K to 297.1 K (-0.17 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.49 | 100 | 2,049 | 297,562 | 297.7 K to 297.6 K (-0.03 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.50 | 100 | 2,050 | 297,662 | 297.8 K to 297.7 K (-0.03 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.52 | 600 | 12,312 | 297,762 | 298.4 K to 297.8 K (-0.20 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.54 | 500 | 10,270 | 298,362 | 298.9 K to 298.4 K (-0.17 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Sell | S | 20.57 | 200 | 4,114 | 298,862 | 299.1 K to 298.9 K (-0.07 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 37,959 | 90,153 | 299,062 | 261.1 K to 299.1 K (+14.54 %) |
Nov 23 2004 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | Chief Executive Off ... | Buy | M | 2.38 | 5,791 | 13,754 | 261,103 | 255.3 K to 261.1 K (+2.27 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 11,250 | 26,719 | 0 | |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Option Exercise | M | 2.38 | 1,875 | 4,453 | 0 | |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.77 | 600 | 12,462 | 28,126 | 28.7 K to 28.1 K (-2.09 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.75 | 100 | 2,075 | 28,726 | 28.8 K to 28.7 K (-0.35 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.76 | 411 | 8,532 | 28,826 | 29.2 K to 28.8 K (-1.41 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.78 | 533 | 11,076 | 29,237 | 29.8 K to 29.2 K (-1.79 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.95 | 567 | 11,879 | 29,770 | 30.3 K to 29.8 K (-1.87 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.90 | 4,341 | 90,727 | 30,337 | 34.7 K to 30.3 K (-12.52 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 21.00 | 659 | 13,839 | 34,678 | 35.3 K to 34.7 K (-1.86 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.58 | 275 | 5,660 | 35,337 | 35.6 K to 35.3 K (-0.77 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.59 | 2,025 | 41,695 | 35,612 | 37.6 K to 35.6 K (-5.38 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.63 | 589 | 12,151 | 37,637 | 38.2 K to 37.6 K (-1.54 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Sell | S | 20.60 | 3,025 | 62,315 | 38,226 | 41.3 K to 38.2 K (-7.33 %) |
Nov 19 2004 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Head of Resear ... | Buy | M | 2.38 | 11,250 | 26,719 | 41,251 | 30 K to 41.3 K (+37.50 %) |